(15 Oct 2021) FOR CLEAN VERSION SEE STORY NUMBER: 4348643
Soon after the pandemic began, India's government, with funding from The Rockefeller Foundation, tasked the country's most advanced bioscience innovation hub — the publicly funded Centre for Cellular and Molecular Platforms, or C-CAMP — with quickly finding a way to locally produce virus test kits and their components.
Over a year later, most Indians can access PCR tests at a fraction of the cost — representing a massive effort by a public-private partnership to set up the local expertise to manufacture these tests within India at a low price.
The price of PCR tests has fallen by near tenfold across the country from when the tests were first made available.
80% of test kits used today in the country are now completely manufactured in India.
This was especially important during the deadly second wave of infections in the country that peaked in May 2021 with more than 400,000 cases being detected each day.
Experts say the scale up in production of test kits and other components of diagnostics have aided India in battling the pandemic and enabled self-sufficiency in molecular diagnostics, it has also created a new market for countries looking to procure diagnostic technologies and test kits.
Find out more about AP Archive: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
You can license this story through AP Archive: [ Ссылка ]
Ещё видео!